C063 | ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE VERSUS DARATUMUMAB-POMALIDOMIDE-DEXAMETHASONE IN PATIENTS PROGRESSING AFTER LENALIDOMIDE MAINTENANCE: AN ITALIAN REAL-LIFE STUDY

In recent years, Isatuximab-Carfilzomib-Dexamethasone (Isa-KD) and Daratumumab-Pomalidomide-Dexamethasone (D-PD) have been recognized as the standard of care for the treatment of lenalidomide (len) refractory patients. However, in the pivotal trials, most patients were treated at second or later re...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	V. Ruocco, C. Liberatore, E. Olivari, M. Tinelli, F. Fazio, E. Favero, C.S. Cartia, N. Sgherza, C. Conticello, R. Mina, M. Gherardini, G. Mele, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, B. Rossini, E. Scomazzon, F. Monaco, E.A. Martino, C. De Magistris, F. Fioritoni, A.M. Cafro, S. Pezzatti, R. Della Pepa, P. Boggione, G. Pietrantuono, V. Tomarchio, F. Vassallo, M.L. Pioltelli, F. Pisani, A. Cagnetta, G. Buda, E. Antonioli, L. Paris, A. Tosetto, P. Musto, E. Zamagni, F. Patriarca, S. Mangiacavalli, R. Zambello, M. Offidani
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Ferrata Storti Foundation 2025-09-01
Serie:	Haematologica
Länkar:	https://haematologica.org/article/view/12827
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!